FDA 503B outsourcing facilities in Missouri
Missouri has 3 FDA-registered 503B outsourcing facilities in the PeptideGrids directory, 2 with FDA drug recalls on record, the earliest registered in 2017. 503B facilities compound sterile medications in bulk under FDA cGMP standards and are a primary supply route for compounded peptides and GLP-1s during drug shortages.
| Facility | City | FDA-registered since | FDA recalls |
|---|---|---|---|
| Apollo Care | Columbia | 2017 | 23 |
| Park Avenue Compounding | St. Louis | 2023 | 2 |
| Apertus Compounding, LLC | Maryland Heights | 2025 | None on record |
503B compounding in Missouri
A 503B outsourcing facility registers with the FDA under the Drug Quality and Security Act and is inspected against cGMP manufacturing standards. In addition to that federal registration, a facility shipping into or operating in Missouri must hold the appropriate state pharmacy license. Verify any facility's current license with the Missouri Board of Pharmacy.
Peptides and GLP-1s compounded in Missouri
Facilities in Missouri report compounding Semaglutide, Tirzepatide to the FDA. PeptideGrids grades the clinical evidence for each. Browse the full GLP-1 and therapeutic peptide databases.
Frequently asked questions
How many FDA 503B outsourcing facilities are in Missouri?
3 FDA-registered 503B outsourcing facilities are listed in Missouri on PeptideGrids, the earliest registered in 2017.
Which Missouri 503B facilities have FDA recalls on record?
2 of the 3 Missouri facilities have FDA drug recalls on record; the table above shows the count per facility.
How do I verify a pharmacy license in Missouri?
Use the Missouri Board of Pharmacy license lookup to confirm a facility's current license status.
Facilities sourced from the FDA registered outsourcing facilities list. Recall counts from the FDA openFDA drug enforcement database.